Abatacept for Patients With COVID-19 and Respiratory Distress
NCT04477642
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Funding
Conditions
COVID-19
Interventions
DRUG:
Abatacept
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
[object Object]
[object Object]
[object Object]